Sign-Aware Graph Contrastive Learning for Drug Repositioning
- 20 May 2025
- journal article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (10) , 7704-7716
Abstract
Drug repositioning, which identifies new therapeutic potential of approved drugs, is pivotal in accelerating drug discovery. Recently, growing efforts are devoted to applying graph neural networks (GNNs) for effectively modeling drug-disease associations (DDAs). However, current GNN-based methods are generally designed for unsigned graphs and fail to gain complementary insights provided by negative links. Despite the proposal of sign-aware GNNs in general fields, there exist two intractable challenges when indiscriminately deploying prior solutions into drug repositioning. (i) How to explicitly connect the nodes within the same set (disease-disease and drug-drug)? (ii) How to design the contrastive learning objective for signed graphs? To this end, we propose a novel sign-aware graph contrastive learning approach, namely SIGDR, which takes both the positive and negative links from signed biological networks into consideration to identify underlying DDAs. To handle the first challenge, we measure the drug and disease similarity and form signed unipartite graphs according to similarity scores. For the second challenge, a signed bipartite graph is then constructed from the annotated DDA dataset. Through dividing above obtained signed graphs into positive and negative subgraphs respectively, we devise the inter-view contrastive learning auxiliary task to enhance the consistency of node representations derived from partitioned subgraphs with the same link type. Extensive experiments conducted on three benchmarks under 10-fold cross-validation demonstrate the model effectiveness. Source code and datasets are available at https://github.com/OleCui/paper_SIGDR.Keywords
Funding Information
- National Natural Science Foundation of China (62072070)
- Fundamental Research Funds for the Central Universities (3132024265)
This publication has 59 references indexed in Scilit:
- Regulation-aware graph learning for drug repositioning over heterogeneous biological networkInformation Sciences, 2024
- DRML-Ensemble: drug repurposing method based on feature construction of multi-layer ensembleJournal of Molecular Modeling, 2024
- Heterogenous biological network multi-task learning model for ncRNA-disease-drug association predictionKnowledge-Based Systems, 2024
- Drug repositioning by multi-aspect heterogeneous graph contrastive learning and positive-fusion negative sampling strategyInformation Fusion, 2024
- GCNGAT: Drug–disease association prediction based on graph convolution neural network and graph attention networkArtificial Intelligence in Medicine, 2024
- AMDGT: Attention aware multi-modal fusion using a dual graph transformer for drug–disease associations predictionKnowledge-Based Systems, 2023
- SLGCN: Structure-enhanced line graph convolutional network for predicting drug–disease associationsKnowledge-Based Systems, 2023
- NCH-DDA: Neighborhood contrastive learning heterogeneous network for drug–disease association predictionExpert Systems with Applications, 2023
- Negative Can Be Positive: Signed Graph Neural Networks for RecommendationInformation Processing & Management, 2023
- Relation-aware Heterogeneous Graph Transformer based drug repurposingExpert Systems with Applications, 2022